Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Current Atherosclerosis Reports|October 4, 2003
The concept of apolipoprotein-defined lipoprotein families and its clinical significancePetar Alaupovic
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 12, 2011
The effect of decreasing renal function on lipoprotein profilesPer-Ola Attman, Ola Samuelsson, Petar Alaupovic
Journal of the Cardiometabolic Syndrome|December 2, 2008
Characterization of the metabolic syndrome by apolipoproteins in the Oklahoma CherokeePetar Alaupovic, Piers Blackett, Wenyu Wang, et al.
Journal of Clinical Lipidology|January 29, 2013
Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetesWenyu Wang, Sohail Khan, Piers Blackett, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 20, 2011
Acute effects of interleukin-6 infusion on apo-B-containing lipoprotein subclasses in humansJohn Bagdade, Bente K Pedersen, Dawn Schwenke, et al.
Biology of Sex Differences|August 18, 2012
Sex differences in HDL ApoC-III in American Indian youthPiers R Blackett, Sohail Khan, Wenyu Wang, et al.
Lipids in Health and Disease|May 30, 2018
LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humansJohn D Bagdade, Bernd Jilma, Lisa C Hudgins, et al.
Kidney International. Supplement|April 16, 2003
Dialysis modalities and dyslipidemiaPer-Ola Attman, Ola Samuelsson, Ann-Cathrine Johansson, et al.
Pageof 5